Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Debt (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Total Debt for 13 consecutive years, with $15.3 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 1.03% to $15.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2025, up 1.03% year-over-year, with the annual reading at $15.3 million for FY2025, 1.03% up from the prior year.
  • Total Debt hit $15.3 million in Q4 2025 for STRATA Skin Sciences, roughly flat from $15.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $15.3 million in Q4 2025 to a low of $500000.0 in Q2 2021.
  • Historically, Total Debt has averaged $11.1 million across 5 years, with a median of $15.0 million in 2023.
  • Biggest five-year swings in Total Debt: crashed 80.22% in 2021 and later surged 1379.0% in 2022.
  • Year by year, Total Debt stood at $7.3 million in 2021, then rose by 2.15% to $7.5 million in 2022, then soared by 101.23% to $15.0 million in 2023, then grew by 0.98% to $15.2 million in 2024, then increased by 1.03% to $15.3 million in 2025.
  • Business Quant data shows Total Debt for SSKN at $15.3 million in Q4 2025, $15.3 million in Q3 2025, and $15.3 million in Q2 2025.